Great Lakes Biologics specializes in the development of biologic product candidates used in biopharmaceutical research and development.
Great Lakes Biologics has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2022.
Great Lakes Biologics's investors include Newchip Accelerator, XLerateHealth.
Great Lakes Biologics is headquartered in Plymouth, United States.
Great Lakes Biologics specializes in the development of biologic product candidates used in biopharmaceutical research and development.
Great Lakes Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Great Lakes Biologics — Funding & Investors." VCBacked, December 30, 2022, https://www.vcbacked.co/company/great-lakes-biologics. Accessed July 27, 2026.
VCBacked. (2022). Great Lakes Biologics — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/great-lakes-biologics
{{cite web |title=Great Lakes Biologics — Funding & Investors |url=https://www.vcbacked.co/company/great-lakes-biologics |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated